HighTower Advisors
GMED icon

HighTower Advisors’s Globus Medical GMED Stock Holding History

HighTower Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200
Closed -$1K – 2435
2019
Q1 		$1K Buy
+200
New +$9.05K ﹤0.01% 2273

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HighTower Advisors's GMED Position: Q2 2026 in Review

HighTower Advisors reduced its Globus Medical (GMED) stake by 13% in Q2 2026, selling an estimated $258K and leaving 20,586 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

HighTower Advisors first reported a position in GMED in Q2 2015 and has held it in 37 quarters since. The position peaked at $3.56M in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • HighTower Advisors held 20,586 shares of Globus Medical worth $1.63M as of Q2 2026.
  • HighTower Advisors sold 3,040 Globus Medical shares in Q2 2026, an estimated $258K.
  • Globus Medical made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1905 holding.
  • HighTower Advisors first reported a position in Globus Medical in Q2 2015 and has held it in 37 quarters since.
  • HighTower Advisors's Globus Medical position peaked at $3.56M in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.